PROFOUND MEDICAL CORP. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
PROFOUND MEDICAL CORP. (PROF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of 9.86 CAD/shares for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2024-03-07
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2023-12-31 | 9.86 CAD/shares 40-F · filed 2024-03-07 |
| 2022-12-31 | 8.45 CAD/shares 40-F · filed 2024-03-07 |
| 2021-12-31 | 9.72 CAD/shares 40-F · filed 2023-03-07 |
| 2019-12-31 | 3.00 CAD/shares 40-F · filed 2020-03-03 |
| 2018-12-31 | 2.40 CAD/shares 40-F · filed 2020-03-03 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2021-12-31 | $9.72 40-F · filed 2022-03-03 | |
| 2020-12-31 | $10.42 40-F · filed 2022-03-03 | $8.18 40-F · filed 2021-03-02 |
| 2019-12-31 | $2.26 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |